ITGB4 as a novel serum diagnosis biomarker and potential therapeutic target for colorectal cancer

PURPOSE: To develop new and effective biomarkers for the diagnosis of colorectal cancer (CRC). EXPERIMENTAL DESIGN: The serum expression of ITGB4 (49 CRC and 367 HC) was detected by enzyme‐linked immunosorbent assay (ELISA), and its diagnostic value was analyzed using the receiver operating characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xia, Wang, Jia, Wang, Mengyu, Xuan, Mingda, Han, Shuangshuang, Li, Chao, Li, Meng, Sun, Xiao‐Feng, Yu, Weifang, Zhao, Zengren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495272/
https://www.ncbi.nlm.nih.gov/pubmed/34414684
http://dx.doi.org/10.1002/cam4.4216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495272/
https://www.ncbi.nlm.nih.gov/pubmed/34414684
http://dx.doi.org/10.1002/cam4.4216

Ejemplares similares